Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Circulation

• Publication date

  1992-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.85.2.504PMID 1735147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelium‐derived relaxing and contracting factors

  1991cited by this paper
• Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

  1991cited by this paper
• Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation.

  1991cited by this paper
• Endothelium-derived relaxing and contracting factors.

  1991cited by this paper
• Comparison of the bronchopulmonary and pressor activities of endothelin isoforms ET-1, ET-2, and ET-3 and characterization of their binding sites in guinea pig lung.

  1991cited by this paper
• Receptors on pulmonary endothelial cells.

  1990cited by this paper
• Analysis of cardiovascular and pulmonary responses to endothelin-1 and endothelin-3 in the anesthetized cat.

  1990cited by this paper
• Biosynthesis and modulation of endothelin from bovine pulmonary arterial endothelial cells.

  1990cited by this paper
• Analysis of endothelin-1-induced contractions of guinea-pig trachea, pulmonary veins and different types of pulmonary arteries.

  1990cited by this paper
• Tissue distribution and half-life of 125I-endothelin in the rat: importance of pulmonary clearance.

  1990cited by this paper
• Endothelin-like pulmonary vasoconstrictor peptide release by alpha-thrombin.

  1989cited by this paper
• Endothelin produces pulmonary vasoconstriction and systemic vasodilation.

  1989cited by this paper
• Neurohormonal influences in the pathogenesis of congestive heart failure.

  1989cited by this paper
• Endothelin-1 constricts human pulmonary resistance vessels in vitro.

  1989cited by this paper
• Endothelium‐derived relaxing and contracting factors

  1989cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Assessment of right and left heart interactions: application of the resistance ratio in chronic congestive heart failure.

  1987cited by this paper
• Assessment of right and left heart interactions: application of the resistance ratio in chronic congestive heart failure.

  1987cited by this paper
• The neurohumoral axis in congestive heart failure.

  1984cited by this paper
• Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.

  1982cited by this paper

• Pathogenesis, histopathology, and mechanisms of pulmonary pathology secondary to chronic left heart failure in animals.

  2026cites this paper
• Prognostic Value of Plasma Big Endothelin-1 in Patients Hospitalized for Heart Failure

  2025cites this paper
• Endothelin-1 influences mechanical properties and contractility of hiPSC derived cardiomyocytes resulting in diastolic dysfunction.

  2024cites this paper
• Investigation of pulmonary artery and circulating endothelin-1 expression in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease

  2024cites this paper
• Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF

  2023cites this paper
• Pulmonary Circulation Under Pressure: Pathophysiological and Therapeutic Implications of BK Channel

  2023cites this paper
• Benefits of Macitentan in Patients with Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2023cites this paper
• The Evolving Management and Treatment Options for Patients with Pulmonary Hypertension: Current Evidence and Challenges

  2023cites this paper
• Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management

  2023cites this paper
• Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre‐ and postcapillary pulmonary hypertension

  2023cites this paper
• Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction.

  2022cites this paper
• Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease

  2022cites this paper
• Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies

  2022cites this paper
• Prevalence and survival associated with pulmonary hypertension after mitral valve replacement: National echocardiography database of Australia study

  2022cites this paper
• Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers

  2022cites this paper
• Retinal microvascular function predicts chronic kidney disease in patients with cardiovascular risk factors.

  2021cites this paper
• Management of Pulmonary Hypertension in Left Heart Disease

  2021cites this paper
• Biomarkers in premature calves with and without respiratory distress syndrome

  2021cites this paper
• Pathophysiological-based treatments of complications of cirrhosis

  2020cites this paper
• Die Bedeutung von Neurohormonen in der Diagnose der Herzinsuffizienz

  2020cites this paper
• Elevated plasma endothelin‐1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure

  2020influential citation
• Cardioprotective Effects of Mebudipine in a Rat Model of Doxorubicin-Induced Heart Failure

  2020cites this paper
• Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers

  2020cites this paper
• Pathophysiology Behind Cardiopulmonary Complications of Cirrhosis and Portal Hypertension

  2020cites this paper
• Reappraisal of Inflammatory Biomarkers in Heart Failure

  2020cites this paper
• Endothelin-Antagonisten in der neurohumoralen Therapie der chronischen Herzinsuffizienz

  2020cites this paper
• Biochemical and imaging markers in patients with thalassaemia.

  2020cites this paper
• Heart Failure due to Left Ventricular Systolic Dysfunction

  2020cites this paper
• Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.

  2020cites this paper
• Plasma Endothelin-1 and Risk of Death and Hospitalization in Patients undergoing Maintenance Hemodialysis.

  2020cites this paper
• Perindopril Improves Cardiac Function in Doxorubicin-Induced Cardiotoxicity Rats

  2020cites this paper
• Epidemiology and pathophysiology

  2019cites this paper
• Increased pulmonary blood volume variation in patients with heart failure compared to healthy controls; a non-invasive, quantitative measure of heart failure.

  2019cites this paper
• Plasma Endothelin in Patients With End-Stage Renal Disease on Hemodialysis

  2019cites this paper
• Obesity and pulmonary hypertension

  2019cites this paper
• Pre-and Postoperative Evaluation of the Effect of Atrial Septal Defect on Systemic Circulation Via Pulse Wave Velocity

  2019cites this paper
• Endothelin and the heart in health and diseases

  2019cites this paper
• Cardiovascular Changes in Children with Acute Lower Respiratory Tract Infection

  2019cites this paper
• Targeting the endothelin system: a step towards a precision medicine approach in heart failure with preserved ejection fraction?

  2019cites this paper
• The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.

  2019cites this paper
• Plasma endothelin-1 and adrenomedullin are associated with coronary artery function and cardiovascular outcomes in humans.

  2019cites this paper
• Effects of Urotensin II on Excitation-Contraction Coupling in Hypertrophic Heart Failure

  2018cites this paper
• Transition from post‐capillary pulmonary hypertension to combined pre‐ and post‐capillary pulmonary hypertension in swine: a key role for endothelin

  2018cites this paper
• Prostaglandin E1 for preventing the progress of pulmonary arterial hypertension in rat model

  2018cites this paper
• Pulmonary hypertension related to heart failure and hypoxia. Mechanisms, new treatment strategies and impact on mortality following heart transplantation. Experiences from Skåne University Hospital in Lund

  2018cites this paper
• Recovery of failing hearts by mechanical unloading: Pathophysiologic insights and clinical relevance

  2018cites this paper
• Macitentan in pulmonary hypertension due to left ventricular dysfunction

  2018cites this paper
• Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: A meta-analysis.

  2018cites this paper
• Management of Pulmonary Hypertension: Associated with Left Heart Disease.

  2018cites this paper
• Intersection of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients on Left Ventricular Assist Device Support: Is There a Role for Pulmonary Vasodilators?

  2018cites this paper
• Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure: A Review

  2018cites this paper
• High-sensitivity C-reactive protein in heart failure with preserved ejection fraction

  2018cites this paper
• Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction.

  2017cites this paper
• Cardioskeletal Myopathies in Congenital Heart Diseases

  2017cites this paper
• Cardiopulmonary and inflammatory biomarkers in heartworm disease

  2017cites this paper
• Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides

  2017cites this paper
• Radiation-induced non-targeted effect in vivo: Evaluation of cyclooygenase-2 and endothelin-1 gene expression in rat heart tissues

  2017cites this paper
• Explorer Direct comparison of selective endothelin A and non-selective endothelin A / B receptor blockade in chronic heart failure

  2017cites this paper
• Propeptide big-endothelin, N-terminal-pro brain natriuretic peptide and mortality. The Ludwigshafen risk and cardiovascular health (LURIC) study

  2017cites this paper
• Pulmonary Hypertension in Left Heart Disease

  2017cites this paper
• A Tale of Two Circulations

  2017cites this paper
• Pulmonary Hypertension in Heart Failure Patients Presenting at OAUTHC, Ile-Ife, Nigeria

  2016cites this paper
• Calcium Handling in Pulmonary Vasculature Under Oxidative Stress: Focus on SERCA

  2016cites this paper
• Association of Elevated Plasma Endothelin-1 Levels With Pulmonary Hypertension, Mortality, and Heart Failure in African American Individuals: The Jackson Heart Study.

  2016cites this paper
• Investigating the mechanisms of p38 activation

  2016cites this paper
• The vasoprotective properties of relaxin in the peripheral vasculature of males

  2016cites this paper
• Pulmonary Hypertension in Patients with Heart Failure and Preserved Ejection Fraction: Differential Diagnosis and Management

  2016cites this paper
• Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects.

  2016cites this paper
• Evolving Concepts on the Basic Mechanisms of Heart Failure

  2016cites this paper
• Polymorphism in Endothelin-1 Gene: An Overview.

  2016cites this paper
• Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies

  2016cites this paper
• Searching for New Biomarkers in Pulmonary Hypertension Due to Left Heart Disease : Results from a Protein Array Analysis

  2016cites this paper
• Endothelin

  2016cites this paper
• Heart Failure Relationship Between Endothelin-1 Extraction in the Peripheral Circulation and Systemic Vascular Resistance in Patients With Severe Congestive Heart Failure

  2016cites this paper
• Pulmonary Hypertension in the Dog

  2016cites this paper
• Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH).

  2016cites this paper
• Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology.

  2016cites this paper
• Clinical and prognostic value of endothelin-1 and big endothelin-1 expression in children with pulmonary hypertension

  2016cites this paper
• Role of endothelin-1 in mediating changes in cardiac sympathetic nerve activity in heart failure.

  2016cites this paper
• Increased mortality with elevated plasma endothelin‐1 in acute heart failure: an ASCEND‐HF biomarker substudy

  2016cites this paper
• Group 2 PH: Medical Therapy.

  2016cites this paper
• Plasma Pro‐Endothelin‐1 Peptide Concentrations Rise in Chronic Kidney Disease and Following Selective Endothelin A Receptor Antagonism

  2015cites this paper
• Pulmonary Venous Hypertension

  2015cites this paper
• The Right Ventricle: A Not-So-Innocent Bystander in Pulmonary Hypertension Due to Left Heart Disease

  2015influential citation
• Circulating biomarkers in pulmonary arterial hypertension: update and future direction.

  2015cites this paper
• Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study

  2015cites this paper
• Reactive pulmonary hypertension in left heart disease “ Post-capillary PH with a pre-capillary component ”

  2015cites this paper
• Impact of pharmacologic interventions--treating endothelial dysfunction and group 2 pulmonary hypertension.

  2015cites this paper
• vascular development in neonatal rats with hyperoxic lung injury Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and

  2015cites this paper
• Left ventricular vs. biventricular mechanical support: Decision making and strategies for avoidance of right heart failure after left ventricular assist device implantation.

  2015cites this paper
• Endothelin A Receptor Antagonist, Atrasentan, Attenuates Renal and Cardiac Dysfunction in Dahl Salt-Hypertensive Rats in a Blood Pressure Independent Manner

  2015cites this paper
• Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases

  2015cites this paper
• Pulmonary Hypertension in Obstructive Sleep Apnea: Is it Clinically Significant? a Critical Analysis of the Association and Pathophysiology

  2015cites this paper
• Diurnal Variation in Blood Pressure and Arterial Stiffness in Chronic Kidney Disease: The Role of Endothelin-1

  2014cites this paper
• Reactive Oxygen Species and Antioxidants in Pulmonary Hypertension and Right Heart Failure

  2014cites this paper
• Pulmonary Hypertension in Mitral Regurgitation

  2014cites this paper
• Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.

  2014cites this paper
• Endothelin 1 gene as a modifier in dilated cardiomyopathy.

  2014cites this paper
• A Temporal Characterization of the TAC and MI models of Heart Failure in CD-1 Mice

  2014cites this paper
• Ischemic Infarction of Cerebral Cortex in a Child with Scorpion Sting Envenomation

  2014cites this paper